– The strongest known risk factor is age, with very low risk in men younger than 50 and increases with age thereafter. – African Caribbean men are three times more likely to be diagnosed with prostate cancer than their white counterparts.About Gen-ProbeGen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests that are diagnose diagnose human diseases and screen donated human blood. Gen-Probe has more than 24 years of NAT expertise , and received the 2004 National Medal of Technology, America’s highest honor for technological innovation, for developing NAT assays for blood screening.

Statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that could cause the actual results, performance or achievements of the company may differ materially from those expressed or implied by forward -looking statements. Information about information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-Q for the quarter March 2007, and all subsequent periodic reports with the SEC from. We assume no obligation and forward-looking statements obligation to update forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.. Forward-Looking StatementsAny statements in this press release about our expectations, beliefs, assumptions or future events or performance are not historical facts and are forward-looking statements.Such study appears in the December issue of the breast, peer-reviewed peer-reviewed journal of the American College of Chest Physicians. Laut der Republik, Salbei.. 6 New research suggests that those patients whose chronic obstructive lung disease copy copy to specific drawings at neuropsychological testing have an increased mortality rate draughtsmanship continues in order to that associated death of patients having COPD. Italian researcher traced 134 patients with stable COPD, aged 68, of a median of 32 months. Patients underwent clinical trials, including spirometry and a 6 – MWT and neuropsychological examination, including a psychological investigation, verbal memory evaluation and simple or complex subscription Reviews.